第一单位：
The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Central Parkway, Newcastle upon Tyne, United Kingdom.
作者：
Ursula,Moore [1]
;
Heather,Gordish [2]
;
Jordi,Diaz-Manera [3]
;
Meredith K,James [1]
;
Anna G,Mayhew [1]
;
Michela,Guglieri [1]
;
Roberto,Fernandez-Torron [1]
;
Laura E,Rufibach [4]
;
Jia,Feng [5]
;
Andrew M,Blamire [6]
;
Pierre G,Carlier [7]
;
Simone,Spuler [8]
;
John W,Day [9]
;
Kristi J,Jones [10]
;
Diana X,Bharucha-Goebel [11]
;
Emmanuelle,Salort-Campana [12]
;
Alan,Pestronk [13]
;
Maggie C,Walter [14]
;
Carmen,Paradas [15]
;
Tanya,Stojkovic [16]
;
Madoka,Mori-Yoshimura [17]
;
Elena,Bravver [18]
;
Elena,Pegoraro [19]
;
Linda Pax,Lowes [20]
;
Jerry R,Mendell [20]
;
Kate,Bushby [1]
;
Volker,Straub [21]
;
Jain COS Consortium
作者单位：
The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Central Parkway, Newcastle upon Tyne, United Kingdom.
[1]
Center for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, United States; Pediatrics, Epidemiology and Biostatistics, George Washington University, Washington, DC, United States.
[2]
Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain; Neuromuscular Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau.
[3]
The Jain Foundation, Seattle, Washington DC, United States.
[4]
Center for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, United States.
[5]
Magnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, United Kingdom.
[6]
AIM & CEA NMR Laboratory, Institute of Myology, Pitié-Salpêtrière University Hospital, 47-83 Paris, France.
[7]
Charite Muscle Research Unit, Experimental and Clinical Research Center, a Joint Cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine, Berlin, Germany.
[8]
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.
[9]
The Children's Hospital at Westmead, and The University of Sydney, Australia.
[10]
Department of Neurology Children's National Health System, Washington, DC, United States; National Institutes of Health (NINDS), Bethesda, MD, United States.
[11]
Service des maladies neuromusculaire et de la SLA, Hôpital de La Timone, Marseille, France.
[12]
Department of Neurology Washington University School of Medicine, St. Louis, MO, United States.
[13]
Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of Munich, Germany.
[14]
Neuromuscular Unit, Department of Neurology, Hospital U. Virgen del Rocío/Instituto de Biomedicina de Sevilla, Sevilla, Spain.
[15]
Centre de référence des maladies neuromusculaires, Institut de Myologie, AP-HP, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
[16]
Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry Tokyo, Japan.
[17]
Neuroscience Institute, Carolinas Neuromuscular/ALS-MDA Center, Carolinas HealthCare System, Charlotte, NC, United States.
[18]
Department of Neuroscience, University of Padova, Italy.
[19]
The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH United States.
[20]
The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Central Parkway, Newcastle upon Tyne, United Kingdom. Electronic address: Volker.straub@newcastle.ac.uk.
[21]
DOI
10.1016/j.nmd.2021.01.009
PMID
33610434
发布时间
2021-11-18
换一批
